Clinical Trials Browser

Interventional × bexmarilimab × Tumor-Agnostic × Clear all

NCT03733990 2025-04-02

A Study to Evaluate Safety, Tolerability and Preliminary Efficacy of FP-1305 in Cancer Patients (MATINS)

Phase 1/2 Completed

216 enrolled 17 charts

Neoplasms